Compound ID | 389
Class: Natural product antibiotic
| Agent Type: | Natural product; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | RNA synthesis inhibitor. Bacterial DNA-directed RNA polymerase inhibitor |
| Target Pathogen: | Active against Streptococcus sp. and Enterococcus faecalis |
| Description: | Natural product from Streptomyces tirandis subsp. umidus; tetramic acid-type antibiotic; structural hybrid of tirandamyicn and streptolydigin |
| Institute where first reported: | Abbott Laboratories, USA |
| Year first mentioned: | 1987 |
| Development status: | Experimental |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/54717174 |
| Guide to Pharmacology: | tirandalydigin |
| Citations: |
|